As a member of The Health Charities Coalition of Canada (HCCC) our organization, Osteoporosis Canada, is pleased to see federal support for the establishment of the Canadian Drug Agency which will oversee the development of a new national formulary of prescribed drugs and provide additional support for Canadians with rare diseases. We look forward to integrating the perspectives of patients and the health charity sector as we work with the Federal Government to implement these investments.
